Come up with a name for your new list and we'll add to it:
Carterra raised a round of funding on January 17, 2018. Investors include
Telegraph Hill Partners.
Carterra, fka Wasatch Microfluidics, is advancing LSA, a fully automated, high-throughput monoclonal antibody (mAb) characterization platform which enables label-free binding experiments to be perform…